Digital Data Deluge Can Affect Oversight Of Patient Safety In Trials
Executive Summary
The digitalization of clinical trials is generating more patient safety data than companies can process. A senior EMA official says sponsors should carefully select what is needed to maintain appropriate subject oversight by “getting the science right.”
You may also be interested in...
Denmark Finds Sponsors ‘Overburdening’ Study Sites To Support Decentralized Trials
A senior Danish GCP Inspector highlights instances of clinical trial sites facing burdensome procedures to support decentralized trials and discusses other challenges posed by such studies.
Global Regulators Outline Quality Expectations For Cell And Gene Therapy Raw Materials
The International Pharmaceutical Regulators Programme explains how manufacturers of cell and gene therapy products can assess and mitigate the potential risks associated with product raw materials.
Patient Groups Back EU Cross Border Clinical Trials Access Initiative
An EU project for framing recommendations and best practices to improve cross-border access to clinical trials is gathering pace.